Cargando…

Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation

BACKGROUND: To compare the apparent diffusion coefficient (ADC) on diffusion-weighted imaging (DWI) with the standardized uptake values (SUV) measured by(18)F-FDG-PET/CT in naïve hepatocellular carcinoma (HCC) nodules, and to determine whether these markers are associated with tumours at high-risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Boussouar, Samia, Itti, Emmanuel, Lin, Shih-Jui, Decaens, Thomas, Evangelista, Eva, Chiaradia, Melanie, Chalaye, Julia, Baranes, Laurence, Calderaro, Julien, Laurent, Alexis, Pigneur, Frederic, Duvoux, Christophe, Azoulay, Daniel, Costentin, Charlotte, Rahmouni, Alain, Luciani, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756529/
https://www.ncbi.nlm.nih.gov/pubmed/26883745
http://dx.doi.org/10.1186/s40644-016-0062-8
Descripción
Sumario:BACKGROUND: To compare the apparent diffusion coefficient (ADC) on diffusion-weighted imaging (DWI) with the standardized uptake values (SUV) measured by(18)F-FDG-PET/CT in naïve hepatocellular carcinoma (HCC) nodules, and to determine whether these markers are associated with tumours at high-risk of aggressiveness. METHODS: From 2007 to 2010, all patients with HCC on the waiting list for liver transplantation and who underwent both FDG-PET/CT and 1.5-T DWI-MRI (b values: 0, 200, 400, and 800 s/mm(2)) were included in this institutional review board-approved retrospective study. Tumour size, tumour ADC, tumour-to-liver ADC ratio (ADC(T/L)), maximal tumour SUV and tumour-to-liver SUV ratio (SUV(T/L)) were measured and compared to serum alpha-fetoprotein (AFP) levels, tumour size and differentiation grade on explanted specimens. RESULTS: A total of 37 HCC nodules in 28 patients were available for correlation between MRI and PET/CT, 7 of which (in 7 patients) showed a SUV(T/L) > 1.15. We did not find any correlation between tumour ADC or ADC(T/L) and tumour SUV or SUV(T/L). To note, SUV(T/L) was positively correlated with AFP levels (R = 0.95, P ≤ 0.0001), while ADC(T/L) was not (P = 0.73). Twenty-four patients (with 32 nodules) underwent liver transplantation. In this subgroup, an increased SUV(T/L) ratio was associated with larger tumours (average size, 32 ± 14 mm; range, 18–60 mm; P < 0.0001) and with poor differentiation on pathology (grades 3 and 4; P = 0.04), while ADC(T/L) was neither associated with tumour size or differentiation grade. CONCLUSIONS: ADC and SUV measures in HCC nodules are not correlated. SUV(T/L) ratio correlates with AFP levels, tumour size and poor differentiation, and should probably be integrated as a co-variable in a predictive outcome model of patients on the waiting-list for liver transplantation.